Photobiomodulation Devices: How Light Therapy Helps Long COVID

Why Light Therapy Is Suddenly on Everyone’s Radar

If you’ve been scrolling through health feeds lately, you’ve probably noticed a surge of buzz around “photobiomodulation,” or PBM for short. The term sounds like something out of a sci‑fi novel, but at its core it’s simply the idea that certain wavelengths of light can nudge our cells into healthier behavior. The MedCram video titled “Photobiomodulation Devices and Research (including Long COVID)” pulls together the latest findings, a handful of commercial devices, and a look at how this light‑based approach might help people wrestling with lingering COVID‑19 symptoms.

What Exactly Is Photobiomodulation?

In plain English, photobiomodulation is the use of low‑level red or near‑infrared light to influence cellular function. Unlike the high‑energy lasers used in eye surgery, PBM devices emit light that’s gentle enough to be applied to the skin without causing burns. The magic happens at the mitochondria—the tiny power plants inside each cell. When photons of the right wavelength hit the mitochondria, they can boost the production of adenosine triphosphate (ATP), the molecule that fuels most cellular activities. More ATP means cells can repair themselves faster, reduce inflammation, and even improve blood flow.

Think of it like giving your cells a tiny espresso shot. The effect isn’t dramatic enough to replace medication, but it can tip the balance toward recovery, especially when the body is stuck in a low‑energy, inflamed state.

From Lab Bench to Living Room: The Devices Making Waves

The video points to two companies that have turned PBM research into consumer‑friendly products: Neuronic and Vielight. Both brands market handheld or head‑mounted devices that emit red (around 630‑660 nm) and near‑infrared (around 810‑850 nm) light. Neuronic’s lineup, for example, includes a sleek, pen‑like wand that you can glide over the scalp or sore muscles. Vielight, on the other hand, offers a headband that delivers light directly to the brain through the temples—a design inspired by early studies showing that transcranial PBM can modulate brain activity.

What’s reassuring is that these devices are built around the same wavelengths that have been studied in clinical settings. The video’s description even links to a PubMed article (PMID 37668791) that reviews the safety profile of low‑level light therapy, noting that adverse events are rare when devices stay within the recommended power density (typically under 100 mW/cm²).

The Science Behind the Hype: Recent Research Highlights

One of the most compelling parts of the MedCram lecture is the discussion of a recent systematic review (see PubMed ID 37668791). The authors sifted through dozens of trials involving PBM for conditions ranging from chronic pain to neurodegenerative disease. A consistent thread emerged: when applied correctly, red and near‑infrared light can reduce markers of inflammation and improve functional outcomes.

For instance, several small trials reported that participants with musculoskeletal pain experienced less discomfort after a series of 10‑minute PBM sessions. In neurological studies, patients with mild cognitive impairment showed modest gains in memory tests after daily transcranial PBM for a few weeks. While the effect sizes aren’t blockbuster‑level, the low risk and ease of use make PBM an attractive adjunct therapy.

What’s especially relevant today is the emerging data on long COVID. A handful of pilot studies have begun to explore whether PBM can alleviate the fatigue, brain fog, and shortness of breath that linger after the acute infection clears. The rationale is straightforward: long COVID appears to involve persistent low‑grade inflammation and mitochondrial dysfunction—exactly the kind of cellular stress that PBM is designed to address.

Photobiomodulation Meets Long COVID: Early Signals of Hope

Long COVID is a moving target; patients report a kaleidoscope of symptoms that can last months. In the video, the presenter highlights a recent open‑label trial where participants used a Vielight headband for 20 minutes a day over a two‑week period. Many reported reduced brain fog and improved energy levels, and objective measures showed a slight uptick in oxygen saturation during a six‑minute walk test.

It’s important to keep expectations realistic. The study was small, lacked a placebo arm, and relied heavily on self‑reported outcomes. Still, the fact that a non‑invasive, at‑home device showed any signal at all is encouraging, especially when conventional treatments for long COVID remain limited.

Beyond the headband, researchers are also testing PBM applied to the chest and abdomen to support respiratory muscles and improve circulation. The underlying idea is that by boosting mitochondrial efficiency in these tissues, patients might experience less dyspnea and recover stamina more quickly.

Practical Takeaways: Should You Try a Light Device?

If you’re curious about giving PBM a shot, here are a few grounded pointers:

• Check the wavelength. Effective PBM typically uses red (630‑660 nm) or near‑infrared (810‑850 nm) light. Devices that stray far outside this range haven’t been studied as thoroughly.
• Mind the dose. Most protocols recommend 4‑10 J/cm² per session, delivered over 5‑20 minutes depending on the device’s power output. Over‑exposure can actually dampen the beneficial response.
• Start slow. If you’re new to PBM, begin with a few minutes a day and monitor how you feel. Most people notice subtle changes—like a slight lift in mood or a reduction in muscle soreness—within a week or two.
• Combine with other healthy habits. Light therapy works best when paired with good sleep, balanced nutrition, and gentle movement. Think of PBM as a supportive layer rather than a stand‑alone cure.
• Consult your clinician. While PBM is low‑risk, it’s wise to discuss any new device with a healthcare provider, especially if you have conditions like photosensitivity, active cancer, or are pregnant.

Both Neuronic and Vielight provide clear user manuals and often include safety warnings—like avoiding direct eye exposure. Following those guidelines keeps the experience safe and effective.

Looking Ahead: Where Photobiomodulation Might Go Next

The MedCram video ends on an optimistic note, suggesting that as more rigorous trials roll out, PBM could carve out a niche in post‑viral rehabilitation, chronic fatigue management, and even mental health. The technology is cheap enough to be scaled for home use, and the underlying science is steadily gaining credibility.

What’s exciting for the broader medical community is the potential to integrate PBM with other emerging modalities—like wearable biosensors that track inflammation in real time. Imagine a future where a smartwatch detects a spike in inflammatory markers and prompts you to start a short PBM session, all without leaving your couch.

Until that day arrives, the best we can do is stay informed, keep an eye on the evolving research, and consider whether a gentle beam of red light might be a useful addition to our health toolbox.